Veraxa Biotech
0 followers
Antibody Screening - Unravelling the full potential of entire immune repertoires (millions of B cells) VERAXA´s unique platform can combine the assessment of antibody binding with its functional capabilities in 1 single screening step, using a proprietary droplet-based microfluidic screening worksta... Read more
Org chart
Christoph Antz
CEO & Co-Founder
Christoph Antz
Collapse
Christoph A. Merten
Co-Founder & Scientific Advisor
Edward A. Lemke
Co-Founder & Scientific Advisor
Michael Ruppert
Head of BD & Licensing
Christine Köhler
Co-Founder & Head of Biotechnology RD-Antibody Production
Anna Pryszlak
Head of Screening
Steffen Runz
Head of Antibody Development
Paul F. Sauter
Head of Chemistry RD
Marian Weiss
Head of Microfluidics
Heinz Schwer Ph.D.
Managing Director/ Chief Business Officer
Yasemin Doeger
Executive Assistant
